title: Predictors of Clozapine Funding in Southwestern Ontario.
authors.affiliation: Ms. Pallaveshi is with the Lawson Health Research Institute, St. Joseph's Health Care, London, Ontario, Canada. She is also with the Department of Psychiatry, Western University, London, Ontario, where Dr. Mak is affiliated. Dr. Rudnick is with the Department of Psychiatry and Behavioral Neurosciences, McMaster University, and with St. Joseph's Healthcare, both in Hamilton, Ontario.
authors.forename: Luljeta
authors.initials: L
authors.lastname: Pallaveshi
authors.affiliation: Ms. Pallaveshi is with the Lawson Health Research Institute, St. Joseph's Health Care, London, Ontario, Canada. She is also with the Department of Psychiatry, Western University, London, Ontario, where Dr. Mak is affiliated. Dr. Rudnick is with the Department of Psychiatry and Behavioral Neurosciences, McMaster University, and with St. Joseph's Healthcare, both in Hamilton, Ontario.
authors.forename: Michael
authors.initials: M
authors.lastname: Mak
authors.affiliation: Ms. Pallaveshi is with the Lawson Health Research Institute, St. Joseph's Health Care, London, Ontario, Canada. She is also with the Department of Psychiatry, Western University, London, Ontario, where Dr. Mak is affiliated. Dr. Rudnick is with the Department of Psychiatry and Behavioral Neurosciences, McMaster University, and with St. Joseph's Healthcare, both in Hamilton, Ontario.
authors.forename: Abraham
authors.initials: A
authors.lastname: Rudnick
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003024:Clozapine / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D056687:Off-Label Use / Q000191:economics*; D009864:Ontario; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine